Menotropins
Menopur (menotropins) is a protein pharmaceutical. Menotropins was first approved as Pergonal on 1975-08-22.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Menopur (discontinued: Humegon, Pergonal, Repronex)
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Menotropins
Tradename | Proper name | Company | Number | Date | Products |
|---|---|---|---|---|---|
| Menopur | menotropins | Ferring Pharmaceuticals | N-21663 RX | 2004-10-29 | 1 products |
Show 3 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| menopur | Biologic Licensing Application | 2024-11-21 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| S0122 | Injection, menotropins, 75 iu |
Clinical
Clinical Trials
435 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infertility | D007246 | EFO_0000545 | — | 20 | 24 | 53 | 66 | 81 | 236 |
| Female infertility | D007247 | EFO_0008560 | N97 | 10 | 3 | 9 | 6 | 24 | 49 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 3 | 3 | 7 | 7 | 15 | 32 |
| Fertilization in vitro | D005307 | — | — | 1 | 3 | 3 | 10 | 9 | 25 |
| Ovulation induction | D010062 | — | — | 3 | 7 | 5 | 3 | 6 | 23 |
| Syndrome | D013577 | — | — | — | — | 1 | 3 | 12 | 16 |
| Hypogonadism | D007006 | — | E23.0 | 1 | 2 | 4 | 6 | 3 | 16 |
| Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | 4 | 4 | — | 1 | 9 | 15 |
| Assisted reproductive techniques | D027724 | — | — | — | — | 3 | 2 | 4 | 9 |
| Endometriosis | D004715 | EFO_0001065 | N80 | 2 | 1 | 1 | 1 | 4 | 8 |
Show 19 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 1 | — | 9 | 11 |
| Male infertility | D007248 | EFO_0004248 | N46 | 1 | 1 | 3 | — | 4 | 8 |
| Helping behavior | D006379 | — | — | — | 1 | 5 | — | 1 | 7 |
| Ovarian hyperstimulation syndrome | D016471 | — | — | 1 | 1 | 1 | — | 2 | 5 |
| Azoospermia | D053713 | EFO_0000279 | N46.0 | — | 1 | 1 | — | 1 | 3 |
| Pituitary diseases | D010900 | — | E23.7 | — | — | 1 | — | 2 | 3 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | 1 | — | 1 | 3 |
| Papillary thyroid cancer | D000077273 | — | — | — | 1 | 1 | — | — | 2 |
| Follicular adenocarcinoma | D018263 | — | — | — | 1 | 1 | — | — | 2 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 1 | 1 | — | — | 2 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Premature menopause | D008594 | — | E28.31 | 2 | 2 | — | — | 7 | 9 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | 1 | — | — | 3 | 4 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | 1 | — | — | 2 | 3 |
| Leiomyoma | D007889 | — | D25 | 1 | 1 | — | — | 1 | 2 |
| Female genital diseases | D005831 | EFO_0009549 | N85 | — | 1 | — | — | 1 | 2 |
| Infections | D007239 | EFO_0000544 | — | 1 | 1 | — | — | — | 1 |
| Ectopic pregnancy | D011271 | — | O00 | 1 | 1 | — | — | — | 1 |
| Salpingitis | D012488 | — | N70.91 | 1 | 1 | — | — | — | 1 |
| Gonadal disorders | D006058 | — | — | 1 | 1 | — | — | — | 1 |
| Fertilization | D005306 | — | — | — | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
| Area under curve | D019540 | — | — | 1 | — | — | — | — | 1 |
| Absorption | D000042 | — | — | 1 | — | — | — | — | 1 |
| Precocious puberty | D011629 | — | E22.8 | 1 | — | — | — | — | 1 |
| Delayed puberty | D011628 | — | E30.0 | 1 | — | — | — | — | 1 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
| Vaccine immunogenicity | D000071497 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 4 | 4 |
| Neoplasms | D009369 | — | C80 | — | — | — | — | 3 | 3 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 3 | 3 |
| Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | — | — | — | — | 2 | 2 |
| In vitro oocyte maturation techniques | D059471 | — | — | — | — | — | — | 2 | 2 |
| Ovarian cysts | D010048 | — | N83.1 | — | — | — | — | 2 | 2 |
| Post-acute covid-19 syndrome | D000094024 | — | — | — | — | — | — | 2 | 2 |
| Ovarian pregnancy | D065172 | — | O00.2 | — | — | — | — | 1 | 1 |
| Oogenesis | D009866 | — | — | — | — | — | — | 1 | 1 |
| Myofibroma | D047708 | — | — | — | — | — | — | 1 | 1 |
Show 69 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Menotropins |
| INN | _ |
| Description | Menotropin (also called human menopausal gonadotropin or hMG) is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins. Menotropins are extracted from the urine of postmenopausal women.
|
| Classification | Protein |
| Drug class | atropine derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 61489-71-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108427 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB00032 |
| UNII ID | 5Y9QQM372Q (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Menotropins
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,618 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,486 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use